
igAN
European Renal Association (ERA) 2024
Stockholm, Sweden
May 23-26, 2024
Abstract and Poster
Impact of Atacicept on Hematuria in IgA Nephropathy: Post-Hoc Analysis of the Phase 2b ORIGIN Study
Floege J, et al.
Abstract and Oral Presentation
Phase 2b ORIGIN Study Open Label Extension With Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria: Week 72 Interim Analysis
Lafayette R, et al.
Industry-Sponsored Symposium
Targeting the Source of IgA Nephropathy: Focus on BAFF and APRIL Pathways
Presented by: Dr. Chee Kay Cheung, Dr. Heather Reich, and Dr. Jürgen Floege